Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Materion Corporation specializes in advanced materials including specialty alloys, beryllium products, metal matrix composites, thin film deposition materials and precision optical coatings. The company serves diverse industries such as aerospace & defense, semiconductors, energy, automotive and life sciences. While it provides enabling technologies for life science applications—such as biophotonics optics—it does not develop therapeutics or diagnostics itself[1][3][5].
Notably involved in high-profile projects like the James Webb Space Telescope and NASA Mars Rover Perseverance missions by supplying critical beryllium components and optical filters[7][8]. The company has a global footprint with over 3,000 employees across more than 30 locations worldwide[6].
In the life sciences sector specifically (via its Balzers Optics division), Materion manufactures sophisticated coatings and coated optical components used in diagnostic/analytical instruments but does not directly develop drugs or medical devices[3].
Financially robust with $1.098 billion value-added sales in 2024; public since 1956[5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Materion.